Winton Group LTD Oramed Pharmaceuticals Inc. Transaction History

Winton Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$12.98 - $29.75 $306,418 - $702,308	-23,607 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$12.13 - $23.82 $36,972 - $72,603	-3,048 Reduced 11.44%	23,607 $519,000
Q2 2021 Aug 10, 2021	BUY	$8.34 - $14.59 $52,767 - $92,310	6,327 Added 31.12%	26,655 $357,000
Q1 2021 Jul 21, 2021	BUY	$4.22 - $11.33 $16,681 - $44,787	3,953 Added 24.14%	20,328 $207,000
Q4 2020 Feb 12, 2021	SELL	$2.48 - $4.64 $29,668 - $55,508	-11,963 Reduced 42.22%	16,375 $69,000
Q3 2020 Oct 30, 2020	BUY	$2.58 - $4.16 $73,112 - $117,886	28,338 New	28,338 $74,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.